Clinical Trials Directory

Trials / Unknown

UnknownNCT01785381

RCT: Added Value of Coordinator for the Management of Hip Fracture Patients

Randomized Controlled Trial: Added Value of Coordinator for the Management of Hip Fracture Patients in a Network of Public Hospitals in Brussels.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
128 (estimated)
Sponsor
Centre Hospitalier Universitaire Saint Pierre · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Introduction: Hip fracture due to osteoporosis is associated with an extremely high mortality morbidity and loss of quality of life. The risk of future fracture after a first hip fracture is increased. Several studies reported that patients who suffered from a fracture are not optimally treated and do not receive osteoporosis treatment after the first fracture episode. Aim: To evaluate whether a coordinator increases the optimal management of osteoporotic fracture patients and hip fracture patients.

Detailed description

Material and methods: Population: Identification in the "IRIS public hospital network of all patients above 50 years" who suffer from hip fracture. Exclusion of those due to high energy fractures and due to known cancer. First observational phase of treatment followed by randomized controlled trials of 2 years. Intervention (RCT): Added value of a coordinator. Measured outcomes : A. New fractures. B. A score of optimal management of osteoporosis. Definition of the score and management: 1. Realization of a bone density measurement. 2. Identification of secondary osteoporosis. 3. Identification of risk factors and calculation of the probability of a future fracture using FRAX score. 4. Attempt to correct risk factors of osteoporosis when possible. 5. Prevention of falls. 6. Prescription of calcium and vitamin D. 7. Prescription of a medical osteoporosis treatment. 8. Report to the general practitioner.

Conditions

Interventions

TypeNameDescription
OTHERAdded value of coordinatorAdded value of coordinator

Timeline

Start date
2012-12-01
Primary completion
2013-03-01
Completion
2014-12-01
First posted
2013-02-07
Last updated
2013-02-07

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01785381. Inclusion in this directory is not an endorsement.